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ABSTRACT
This quality improvement project aims to increase the providers' knowledge based on the current
literature, the potential dangers of WAGs exposure, and ways providers can reduce exposure
levels.
Background: The OR's concentration, effects, and reduction strategies are well addressed.
Nevertheless, studies that address the exposure of WAGs in perioperative providers in the PACU
are limited.
Methods: An in-depth inquiry was conducted using CINAHL, PubMed, and MEDLINE, to
withdraw studies from 2014 to 2021 related to the PICOT question, of which eight articles were
appraised. Then, an invitation of CRNAs solely to partake in a pre-test survey, followed by the
educational module implementation and a post-test survey. Statistical analysis was applied to
assess the impact of the educational intervention.
Results: There was a 60% increase in knowledge for the organization responsible for setting
exposure limits to WAGs, also a 20% to 30% increase in the participant's ability to distinguish
between the short- and long-term effects of WAGs exposure. Seventy percent of participants
identified at-risk providers to WAG exposure. Finally, all participants knew that chronic WAGs
had been linked to short- and long-term effects.
Discussion: There was increased knowledge regarding WAG exposure, adverse effects, and
practices that reduce its exposure. Considering the limitations of the project and little research
focused on mitigating WAGs exposure in the PACU, further research is needed. Limitations
include the sample size of 10 participants and the virtual delivery of the educational module.

Keywords: PACU, perioperative providers, WAGs, adverse health effects, exposure.
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INTRODUCTION
Advancement in technology and treatment approaches has given rise to a more complex
healthcare system that is multifaceted, involving different specialties and disciplines. One of the
specialties is anesthesiology. Anesthesiology is a highly stressful discipline that entails complex
continuous monitoring, vast knowledge of pharmacology, and the ability to intervene during a
rapid decline. This is related to the fact that anesthesia encompasses ensuring safety to and from
the deliberate progression of loss of awareness, suppression of the autonomic nervous system,
blunting nociception response and perception, and loss of sensation, in addition to the absence of
recollection.1-3 With such goals, anesthesia providers employ different techniques, such as total
intravenous anesthesia, inhaled anesthetic agents, or a mixture of both.3 The decision of what
anesthetic technique is utilized depends on the patient's health record, the type of surgical
procedure, and surgeon preference. The sedative effects are rapid onset and offset with
whichever anesthetic technique is chosen. The inhaled anesthetic agents currently utilized in the
United States (US) to achieve general anesthesia are volatile agents, including desflurane,
isoflurane, sevoflurane, and nonvolatile agent nitrous oxide.1,3
Background
Since the 1800s, inhaled anesthetics have been a technique utilized. As the years
progressed, improved and safer volatile agents were developed, and older agents were abandoned
due to their toxic effects.4 The inhaled anesthetic technique is utilized by an estimated 20 million
people undergoing surgery in the US. During the administration of inhaled anesthetic gases and
up to an hour after administration, small quantities of vapor and waste anesthetic gases (WAGS)
leak from the patient breathing zone or apparatus into the environment because the anesthesia
machine is not airtight.2,5 WAGs are small amounts of volatile anesthetic gases that leak into the
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environment; consequently, certain providers are exposed to these volatile agents while
administering inhaled anesthetics in the operating room (OR) and post-anesthetic care unit
(PACU).2,4-6 Providers at-risk for exposure includes anesthesiologist, surgeons, nurse
anesthetists, OR nurses, OR technicians, PACU nurses, and other PACU personnel.6 The use of
inhaled anesthetic agents poses an additional occupational risk for providers compared to other
anesthetic techniques.4 Exposure to WAGs cannot be eradicated as the anesthesia apparatus is
not airtight. Post-extubation, patients still eliminate the vapors within their breathing zone;
nevertheless, the goal is to limit or reduce exposure.7 The National Institute for Occupational
Safety and Health (NIOSH) set the exposure limit to WAGS in the US: nitrous oxide at 25 parts
per million (ppm), halogenated agents at two ppm, and when used in combination with nitrous
oxide at 0.5 ppm.7
Problem Identification
When patients arrive in the PACU, trace amounts of anesthetic waste gas are still
released with each breath. Exposure to volatile anesthetics depends on the time the agents were
continuously administered and the concentration of the agent in their breathing zone.7 Breathing
zone, as defined by the Occupational Safety and Health Administration (OSHA), is an area
encompassing the face by approximately 6 to 9 inches.8 Random measurement of WAGs samples
in the PACU may show low levels; however, the breathing zones of the perioperative providers
near the recovering patients may expose them to levels higher than the NIOSH set limits.8 There
is an increase of WAGs exposure in a setting where there are no scavenging systems or proper
ventilation in the OR and in the PACU where the ventilation or scavenging system is not
working correctly.6 Current studies suggest that potential perioperative providers' exposure to
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WAGs exceeds NIOSH limits, considering that such levels in the patient breathing zones surpass
as much as 49% of the time.8
Chronic exposure to WAGs has been linked to both short-term and long-term effects.
Short-term effects include nausea, drowsiness, headache, fatigue, irritability, and difficulties with
judgment and coordination. While long-term effects include infertility, premature births, cancer,
congenital abnormalities, spontaneous abortion, and renal and hepatic diseases.5-10 Even with
proper scavenging systems and air-conditioning, total elimination of WAGs is impossible.10 The
severity of the adverse health effects are directly related to the concentration of WAGs exposed
to and the duration of time. For example, at-risk providers' exposure over 22 months was found
to have an increased risk of DNA damage and oxidative stress compared to those exposed for 12
months.10 This begs the research question are (P) perioperative providers (I) who are exposed to
waste anesthetic gases in the PACU (C) compared to providers in a different specialty (O) at
increased risk for adverse health effects (T) over four months?
Scope of the Problem
The risk of exposure is not limited to the OR. When the patient arrives at the PACU,
measurable amounts of WAGs are exhaled, as inhaled anesthetics are primarily eliminated
through the lungs, especially during the first recovery hour. The first hour of recovery is critical,
requiring more vigilance and bedside attendance from perioperative providers, thus compiling
the underrated period of increased exposure for perioperative providers.7,11 Procedural areas such
as the OR have implemented ways and techniques to reduce WAGs by scavenging and lessening
the potential adverse health effects. However, a limited number of research studies address the
risk of perioperative nurses' exposure in the PACU.8 In the US, there is an estimated 528,197
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perioperative nurses, so more than 250,000 are potentially exposed to WAGs. Females account
for more than 78%, while males account for 15%.5,12
Consequences of the Problem
Although there is varying consensus in the literature about specific adverse health effects
of WAGs exposure, multiple studies have documented increased exposure levels' consequences.
Emara et al. conducted a study that evaluated the consequences of long-term exposure to WAGs
on the immune system. Results showed elevated levels of IgE, IgM, and IgG. There is a
correlation that WAGs can cause immunomodulation by causing changes in host leukocytic
counts, lymphocyte activity, and ratios of lymphocyte subpopulations, possibly causing immune
dysfunction.13 In addition, short-term effects such as syncope, headache, dizziness, and fatigue
were reported during working hours which can pose patient safety concerns, particularly when
judgment is impaired.13 WAGs have also been linked to hepatic alterations. Emara et al.
measured hepatic biomarkers and showed increased plasma inorganic fluoride, HFIP, and liver
toxicity markers.2 Exposure to WAGs has also been linked with genotoxicity.9
Knowledge Gaps
Further research is needed to test the potential hazards in pregnant staff, as WAGs can
induce genome instability and fetal neuronal damage.14 The operating room has been typically
connected to exposure to high concentrations of WAG. However, little is known about potential
dangers related to continuous trace exposure in the PACU. Customarily, the PACU is not viewed
as an area with an increased risk of exposure to WAG, which is why scavenging devices are not
routinely used. However, recent studies demonstrate the possibility of surpassing NIOSHrecommended guidelines in the PACU.11 The literature is limited when it comes to WAGs
exposure in PACU.
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Proposal Solution
Regarding WAGs exposure, the bulk of literature and techniques to mitigate its adverse
effects and prolonged exposure focuses mainly on the OR environment. Increasing providers'
knowledge of the problem and its effects is a good start when proposing any solution. Some
studies have shown that in the breathing zone of the post-anesthesia patient, the level of WAGs
eliminated is far greater than the set limits established by NIOSH.8-9,11 Furthermore, a study by
Boiano and Steege concluded that precautionary practices and recommendations were lacking
among providers to varying degrees.5 The proposed solution is an educational module detailing
perioperative providers' risk of WAG exposure, thus creating steps to reduce exposure
consciously. Williams et al. conducted a study to evaluate WAGs exposure and reduction using
an ISO-Gard mask in the PACU. They found that the WAGs level was higher than two ppm for
the one-hour evaluation period, and the mask effectively reduced the amount of exposure.8
SUMMARY OF LITERATURE REVIEW
Rationale/Objective
The OR's concentration, effects, and reduction strategies are well addressed.
Nevertheless, studies that address WAGs' exposure to perioperative nurses in the PACU are
limited. Additionally, the long-term effects of inhaled anesthetics agents are still inconclusive,
especially in perioperative nurses. The literature review aims to examine the existing research on
the adverse effects of WAGs exposure in perioperative nurses that work in the PACU and
examine existing literature on the WAGs levels in the PACU compared to the limit set by the
NIOSH.
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Methodology/Eligibility Criteria
In order to solve the PICOT question, are (P) perioperative providers (I) who are exposed
to waste anesthetic gases in the PACU (C) compared to providers in a different specialty (O) at
increased risk for adverse health effects (T) over four months? A thorough analysis of the
existing literature was done. The inquiry used search engines like MEDLINE, PubMed, and the
Cumulative Index of Nursing and Allied Health Literature (CINHAL) to extract pertinent
research findings. The catchphrases utilized in the inquiry incorporated a mix of 'waste anesthetic
gases or volatile gases or inhaled anesthetics or volatile agents,' AND 'exposure,' AND 'side
effects or adverse effects,' AND 'PACU or recovery unit,' and 'recovery nurses or postoperative
nurse.' With the Underlying inquiry generating several studies, studies were excluded based on
the pertinence related to the PICOT question, English as the language printed in, printed between
the year 2014 to 2021, availability of an abstract, and full-text accessibility.
Following the inquiry restrictions to particular inclusion criteria, 229 studies were
retrieved. Examining the studies' abstracts and titles resulted in 19 studies being included.
Repeated studies were eliminated, lowering the number of articles to 15. Nevertheless, 7 studies
were eliminated based on the need for the availability of the entire print. The remaining 8 articles
were further appraised by reading the full text and chosen for this literature review. The findings
were divided into common themes of adverse health effects and exposure levels in PACU.
Study Characteristics
Adverse Health Effects
Exposure to WAGs predisposes at-risk healthcare providers to short-term and long-term
effects. Long-term adverse effects from WAGs are highly debatable. Current literature shows
that exposure to WAGs long-term has led to infertility, congenital disabilities, miscarriages,
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premature births, cancer, and liver and kidney diseases. While short-term adverse effects of
WAGs exposure have been attributed to nausea, headache, drowsiness, and reduced work
productivity due to fatigue, judgment, and coordination difficulties.2,5,9
Emara et al.2 conducted a comparative cross-sectional study to identify variations in
hepatic and hematological factors from prolonged WAGs exposure among vulnerable healthcare
staff. The study was conducted between October 2018 and January 2019, and 180 participants
were used, involving several healthcare facilities in Saudi Arabia in the Qassim region.
Furthermore, the participants were allocated into control and exposed groups. The control group
consisted of 60 healthy males who were never exposed to inhaled anesthetics vapors, and the
other 120 participants were males working in areas with significant long-term exposure to
WAGs, such as OR employees, including surgeons, surgical assistants (SA), anesthesiologists,
anesthesiologist assistants (AA), nurses, and technicians.2 The study subjects were instructed to
fast overnight. A 10ml blood sample was collected in the morning between 0800 and 0900,
which included the evaluation of complete blood counts (CBC), plasma fluoride and
hexafluoroisopropanol (HFIP) levels, aspartate aminotransferase (AST), alanine
aminotransferase (ALT), alkaline phosphatase (ALP) and serum osteopontin (OPN).2 Results
showed that compared to the control group, the plasma fluoride and HFIP concentrations were
more significant in all exposed groups; however, levels were significantly increased in
anesthesiologists and AAs in the exposed group. The CBC revealed a substantial drop in
hemoglobin, hematocrit, platelets, red blood cells, mean corpuscular volume, mean corpuscular
hemoglobin, and mean corpuscular hemoglobin concentration in the exposed group instead of
the control group.2 Furthermore, the exposed group's white blood cells, granulocytes, and
lymphocytes were significantly high; however, monocyte levels decreased.2
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Compared to the control group, the ALT and AST concentration analysis showed an
elevation in all the exposed groups; ALT was specifically more elevated in the surgeons and AA
samples. While the AST concentration was substantially increased in nurses, surgeons, AAs, and
anesthesiologists.2 ALP concentrations were higher in the blood sample collected from
anesthesiologists, AA, and surgeons. Serum OPN was substantially elevated in the exposed
group, specifically among AAs, surgeons, and anesthesiologists. Lastly, the serum albumin
concentration was reduced in the exposed group.2 The significance of the differences in the
exposed and control groups was analyzed using a one-way ANOVA and a Dunnett test.2 The
research concluded that the hematopoietic system is sensitive to inhaled anesthetic agents' toxic
effects, thus inciting anemia, based on the decreased parameters in the CBC analysis.
Furthermore, reducing blood flow to the liver is correlated with inhaled anesthetic agents' toxic
effects, producing toxic metabolites and altering liver markers.2
Another study examined the effect of WAGs exposure on the immune system. Emara et
al.13 aimed to analyze the consequences of long-term exposure in at-risk healthcare providers.
The study was conducted over five months between October 2018 and January 2019 with a
sample size of 180 subjects, including two groups consisting of 60 healthy males for the
controlled group and 120 at-risk healthcare providers, further subdivided into their disciplines,
i.e., AAs, surgeons, anesthetists, nurses, technicians, and SAs. A fasting 10 ml blood sample was
collected into a silicon-coated tube between 0800 and 0900. Which included the evaluation of
Immunoglobulins IgA, IgG, IgE, IgM, CD3, CD4, CD8, CD4/CD8 ratios, total lymphocyte
counts, serum fluoride, and HFIP.13 The differences and significant results were evaluated using
one-way ANOVA and a Dunnett test. It showed that plasma fluoride and HFIP levels were
increased in the exposed group compared to the control group, especially in the anesthetist and
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AA group. The Serum IgE, IgM, IgG, and IgA in all the exposed groups were considerably
elevated to varying degrees. SAs were the only subgroup sample that failed to reveal any
substantial elevation in the IgE concentration. All the exposed subdivisions showed a significant
elevation in total lymphocyte levels; however, CD3 concentration showed no significant change.
A reduction in CD8 and significant elevation of CD4 and CD4/CD8 ratios were only in the
anesthetists and AA group.13 Emara et al. detailed a positive correlation between plasma fluoride
levels with lymphocytic counts, percentage of CD4, CD4/CD8 ratios, serum IgE, IgG, and IgM,
but not with IgA, CD8, and CD3. In the conclusion of the study, with the various increases and
decreases noted, there is a possibility of immune dysfunction in healthcare workers exposed to
WAGs.13
Lastly, Cakmak et al.9 researched the genotoxicity risk of OR and PACU providers due to
exposure to WAGs. The study sample size included 46 at-risk healthcare providers, 13
anesthetists, 13 OR nurses, 8 OR technicians who had contact with volatile agents such as
nitrous oxide, sevoflurane, and desflurane, and 12 PACU nurses from the same hospital in
Turkey. The study's control group consisted of 21 healthy providers from another specialty or
unit that did not have a prior work history in the OR and PACU. Before sampling, a detailed
questionnaire was also utilized, including demographic information, smoking history, alcohol
intake, body mass index, and any recent diagnostic X-ray examination. Post-shift urine was
retrieved to assess inorganic fluoride levels. Blood samples were collected, delivered to the
laboratory on the same day, and processed within five hours of sampling for the micronucleus
test to assess peripheral blood lymphocytes (PBLs). Also, buccal epithelial cells (BECs) were
collected by utilizing a pre-moistened tongue depressor and scrubbing both sides of the inner
cheeks, and the participants rinsed their mouths.9
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Additionally, passive exposure samples were collected in the providers' breathing zone.9
IBM SPSS version 17.0 software and ANOVA were used to analyze the data collected. The
results showed that the OR air sevoflurane concentration in the three ORs measured was 0.32,
0.38, and 0.58 ppm, while the PACU level was 0.43 ppm.9 Urine sevoflurane was not detected in
the control group, while although detected in the OR and PACU, comparatively, the levels
detected were similar. Urine sevoflurane levels surpassed the biological norm in 23 participants:
9 anesthetists, 5 nurses, 3 technicians, and 6 PACU. Compared to the control group, the
micronucleus frequency in PBL was substantially increased, and a threefold increase in BECs in
the exposed group, especially those exposed to sevoflurane, the principal inhaled anesthetic
agent used in this research study. Hence, based on the micronucleus frequencies in PBL and
BEC results, it reflects high chromosomal instability and genotoxicity.9
Exposure Levels in PACU
The NIOSH sets the exposure limit for WAGs in the US, but the OSHA enforces the
exposure limit. Most of the literature published addresses the exposure levels in the OR.
However, it is imperative to note that recommended levels apply anywhere inhaled anesthetics
are utilized and in the PACU.8 WAGs exposure concentration is dictated by the level of inhaled
anesthetics in the breathing zone, and the time the gas is constantly inhaled.8
Five studies for the literature review evaluated the exposure levels in the PACU.
Williams et al.8 conducted a prospective observational study over four months to evaluate WAGs
measurement in nurses' breathing zone emitting from patients who obtained volatile anesthetics
during the first recovery hour in the PACU. The study included 125 patients booked for
outpatient surgery with an inclusion criterion of greater than 18 years, duration of procedure
greater than two hours, inhaled anesthetic agents as the primary form of sedation, and expected
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to stay in the PACU for at least an hour.8 In addition, 24 nurses were also recruited to participate.
Aside from determining the number exhaled from the patients postoperatively, the authors' aim
was also to examine the extent of PACU nurses' exposure. The participants' breathing zone's
WAG levels were constantly assessed at thirty-second intervals for an hour. The result revealed
that WAGs were more substantial than two ppm within the patient's breathing zone during the
first recovery hour. Also noteworthy was that the number of WAGs measured in the PACU
nurses' breathing zone was more significant than the NIOSH recommended limits, measuring at
concentrations greater than two ppm during the same time frame.8
Similarly, Hiller et al.15 conducted an observational study to measure sevoflurane WAG
concentration in the PACU. They measured the breathing zone of a patient who only received
sevoflurane, was extubated in the OR, and recovered in a PACU that met the engineering
standards of NIOSH. Measurement was taken with a compact, calibrated Miran infrared
spectrophotometer attached to a wand positioned 8 inches from the patient's mouth during the
first hour of recovery. The results showed that exposure levels exceeded recommended limits for
the PACU nurses during the times' the measurements were taken.15
Another prospective observational study by Herzog-Niescery et al.16 from October 2017
to January 2016 in a German University hospital assessed PACU providers' exposure to
sevoflurane during direct patient care by monitoring pre-and post-shift urinary sevoflurane
levels. In addition, air pollution levels were measured in the PACU and hallways around the
PACU. Pollution was measured at the height of 150 cm ten times within 9 hours, and the
patient's breathing zone levels were calculated 25 times in one hour. For their result analysis,
excel 2007 and IBM SPSS version 20 were utilized. The result showed measurable gas peaks and
increased significantly from baseline during regular working hours. The highest sevoflurane
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levels were measured 15 minutes after the patient's arrival. Compared to pre-shift sevoflurane
urine levels, post-shift levels were considerably higher.16 In contrast, Heiderich et al.14 conducted
a prospective observational study of WAGs concentrations in PACU. They assess levels of
WAGs to room size, patient numbers, and ventilator settings. The study occurred in two different
PACU in Germany for a week from 23 to 29 November 2016. Samples were taken in the center
of the rooms at five-minute intervals using a compact ion mobility spectrometer.14 The result
showed low trace amounts of sevoflurane in 805 out of 970 samples, hence not exceeding the
exposure limit.14
Lastly, McGlothlin et al.11 conducted a descriptive and comparative study to evaluate and
control WAGs in the PACU. The study included 19 patients with an inclusion criterion of
healthy, age greater than 18, inhaled anesthetic agents were the primary form of sedation, and
females had negative pregnancy tests. Samples were taken using a Miran wand at six inches over
the patient's mouth and nose and three feet from the side of the patient mouth and nose to capture
the breathing zone for about 50 minutes for every participant. After comparing the controls and
cases in the case-control study to WAGs' exposure to PACU nurses using standard mean and
standard deviation formulas. The result showed that exposure to nitrous was 2.9 times increased
than that of nurses whose patient was utilizing an ISO-Gard mask at 6 inches. While at three feet,
there was a 1.6 times increase.11 The result was also similar for sevoflurane exposure; at both 6
inches and 3 feet, exposure levels were substantially elevated in exposed nurses compared to the
control group.11
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nurses' 6-inch
breathing zones
over four months.

variables.

patient
breathing
The minimum,
zone was 19.5
average,
minutes in
maximum, and
group 0 and
aggregate WAG
13.5 minutes
levels in PACU
in group 1.
between control
The median
groups and the
proportion of
study were
MAX-WAG
evaluated using the for the
Wilcoxon rankcollection
sum test and twoperiod was
sample t-test.
32.2% and
Statistical
22.4 % in
evaluations were
groups 0 and
performed
1,
utilizing SAS 9.4. respectively.
Within the
nurses'
breathing
zone, the
median
MAX-WAG
was 1 minute
in group 1
and 3 minutes
in group 0. In
contrast, the
median
proportion
was 2% in

recovery.
Additionally,
the NIOSH
limit exceeded
the PACU
nurses'
breathing zone
as levels read
more than two
ppm.
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Hiller et
al,15 2015

To measure
sevoflurane
WAG
concentration
in PACU
while also
accounting
for factors
that affect
inhaled
agents'
elimination.

Observational pilot study
Level II

Conducted in the
PACU at
Memorial
Hermann
Hospital in
Texas.
Air exchangers
were verified to
meet NIOSH
standards for
ventilation.

Constant
variables with
normal
distribution were
registered as
standard
deviation, while
skewed were
reported as
median and
interquartile
range. SAS 9.3
was utilized to
perform all
statistical
analyses.

20 adult day
surgical patients
meeting the
research inclusion
criteria were
selected with an
additional
requirement of
remaining in the
PACU for at least
an hour.
Intraoperatively
end-tidal
sevoflurane levels
and temperature
were logged at 10
minutes intervals
from induction
until extubation.
In PACU,
emanated WAG
from the patient
breathing zone was
calculated with a
portable, calibrated
Miran 1B infrared
spectrophotometer,
with a usable

group 1 and
4.7% in group
0.
The median
duration of
the anesthetic
was 100
minutes, and
the
concentration
was 2.1.
The
maximum
sevoflurane
WAG
concentration
exceeded
recommended
exposure
limits in the
patient
breathing
zone for
every 5
minutes of
measurement.

Exposure levels
exceeded
recommended
limits for the
PACU nurses
during the
measurement
times.
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range of 0.03 to
100 ppm.

HerzogTo assess the Prospective
Niescery et PACU
observational study
16
al, 2019
workers'
Level II
environmenta
l and
biological
sevoflurane
burden during
patient care.

A prospective
observational
study was
conducted in a
German
University
Hospital between
2017 and January
2018.
Microsoft Excel
and IBM SPSS
version 20 were
utilized for
statistical
analysis.

A wand is attached
to the analyzer and
positioned for
measurement at 8
inches directly
above the patient
mouth during the
first phase of
recovery.
Air pollution
samples were
taken in the PACU
and corridor
around the PACU
area with a
photoacoustic gas
monitoring device.
Pollution was
measured at the
height of 150cm
ten times for nine
hours, and the
patient's breathing
zone was
measured 25 times
in one hour.
Pre-and post-urine
sevoflurane and

Air pollution
in the center
of the PACU
unit mean
sevoflurane
levels was
0.34 ± 0.07
ppm, and a
max of 4.43 ±
2.37 ppm
daily.
In the
patient's
breathing
zones, the
daily max
was 1.74 ±
1.54, and the
mean was
0.44 ± 0.10

PACU workers
are biologically
and
environmentall
y exposed to
sevoflurane
during patient
care as there
were
measurable gas
peaks and
increased
significantly
from baseline
during regular
working hours.
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HFIP levels were
measured.

ppm.
The mean
sevoflurane
level was
0.47 ± 0.06
ppm in the
corridor and
was
substantially
elevated than
in the PACU.

Heiderich
et al,14
2018

To assess
levels of
inhaled
anesthetics
agents to the
number of
patients,
ventilator
settings, and
room size in
different
PACU.

Prospective
observational study
Level II

The measurement
was taken with a
compact closed
gas loop highresolution ion
mobility
spectrometer to
trace sevoflurane
concentration.

Two PACU in
Hannover Medical
School in
Germany were
researched for one
week.
One hundred forty
patients were
monitored in
PACU 1 and 70 in
PACU 2.

Urinary
sevoflurane
and HFIP
levels were
increased
from their
pre-shift
baseline.
In PACU 1,
the peak
detected level
of
sevoflurane
was 0.96 ±
0.20 ppm,
and the
median was
0.34 ppm,
although it
fluctuated

Occupational
limits were not
exceeded in the
samples
collected
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over time.
Automated
samples were
taken every 5
minutes in the
center of the room.
The Shapiro-Wilk
test was utilized
for the study's
statistical analysis.
McGlothli
n et al,11
2014

To evaluate
the efficacy
of a new
scavenging
and control
WAGs in
PACU.

Descriptive and
comparative study
Level III

Patients were
brought to the
PACU still
intubated and
extubated in the
PACU to set up a
standardized start
time for WAG
measurement.

The study included
19 patients: a
control group of 9
patients utilizing a
nasal cannula or
face mask and 10
cases with ISOGard utilization.

Samples were
taken from 6
inches over the
patient's nose and
mouth with a
Miran wand for
A certified
about 50 minutes
outside contractor for each patient.
conducted
airflow and air
IR
exchange
spectrophotometer
assessments
s were used to
The ISO-Gard
mask was put on
the patient face
once extubated.

In PACU 2,
the highest
detected level
of
sevoflurane
was 0.82 ±
0.07 ppm,
with a median
of 0.28 ppm.
Using the
standard
deviation and
means
formulas, the
average
nurses'
exposure to
nitrous oxide
at six inches
for the
control group
compared to
the case study
group was
69.10 ± 62.77
and 23.99 ±
28.57 ppm,
respectively.
At

Exposure to
nitrous was 2.9
times increased
than that of
nurses whose
patient was
utilizing an
ISO-Gard mask
at six inches.
While at three
feet, there was
a 1.6 times
increase.
Similarly, at
both six inches
and three feet,
exposure levels
were
substantially
elevated in
exposed nurses
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before the
commencement
of the research
and seven months
after.

quantify nitrous
oxide and
sevoflurane levels.
It was positioned
above the patient's
head.

approximatel
y three feet,
the average
nurse's
exposure to
nitrous oxide
is 11.91 ±
5.61 ppm
when the
nasal cannula
is utilized. In
contrast, the
average
nurse's
exposure to
nitrous oxide
is 7.40 ± 4.61
ppm when the
ISO-Gard
mask is
utilized.
Sevoflurane
levels at six
and three feet
were
significantly
reduced when
an ISO-Gard
was used
compared to
when just a
nasal cannula

compared to the
control group at
sevoflurane
exposure.
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was used. It
was
approximatel
y 2.7 times
higher.
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DISCUSSION
Most of the literature focuses on mitigating WAG exposure in the OR environment. The
critical period for a patient during recovery is the first hour. The perioperative provider needs
increased vigilance and direct care; however, the first hour is also attributed to significantly
increased WAGs in the breathing zone of a patient who received inhaled anesthetic agents. 5
studies highlighted the concentration of WAGs in the PACU. Although the studies were
conducted in different locations, with similar inclusion criteria, sample sizes, and methodology,
four conclusions were identical. The findings concluded that the levels of WAGs exceeded the
NIOSH recommended limit, especially during the first fifteen minutes to an hour, putting PACU
nurses at increased risk for exposure and adverse health effects.8,11,15,16 However, 1 of the studies
did not detect a significant number of WAGs in the PACU; instead, it detected just traces.14
Short-and long-term effects were documented in the literature, although debatable. Three
studies by different authors highlight various adverse health effects attributed to WAG exposure,
including genotoxicity and increased variation in hematologic, immunological, and hepatic
parameters.2,9,13 CBC reflected a substantial reduction in hemoglobin, hematocrit, platelets, and
red blood cells, while white blood cells, granulocytes, and lymphocytes were significantly
increased.2 With micronucleus frequency in PBL and BECs substantially increased, it reflects
high chromosomal instability and genotoxicity, the main factor in the carcinogenic process.9
Additionally, all the hepatic biomarkers were elevated in the exposed group.2 In all 3 studies, the
variables measured were substantially higher than the control group consisting of other
specialties not exposed to WAGs in the OR and PACU. Thus, it is safe to conclude that PACU
nurses are at increased risk for adverse effects than nurses of other specialties. Most studies were

Lukoh 28
conducted over a short span, the longest being over five months. As a result, data for the longterm effects of WAG exposure are inconclusive.
ORGANIZATION ASSESSMENT
Purpose/Objective
Traditionally, the PACU is not perceived as a workspace with increased risk for WAGs
exposure, which is why scavenging systems are not routinely used. This quality improvement
project's primary goal and desired outcome are to increase the providers' knowledge based on the
current literature, the potential dangers of WAG exposure, and ways perioperative personnel can
reduce their exposure levels. The population of focus is perioperative providers. Intervention is
an educational module on WAGs exposure and ways to mitigate its adverse effects. The outcome
is to increase provider knowledge of WAGs effects and adherence to safety practices.
Goals/Outcomes
The acronym SMART was used to aid in developing the goals, objectives, and outcomes
of this project. SMART stands for specific, measurable, achievable, realistic, and timely.
Specific
Perioperative providers at a large hospital will be provided with an educational module
detailing the potential for WAG exposure in the PACU and the resulting short- and long-term
adverse health effects recommended evidence-based practice for the reduction of WAGs
exposure.
Measurable
By utilizing surveying software such as Qualtrics, a pre-survey and post-test survey will
be disseminated to the perioperative providers at a large hospital to assess the effectiveness of
the educational module.
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Achievable
Collaborating with an in-facility preceptor to implement the virtually administered
educational module ensures the goal is achievable.
Realistic
Perioperative providers will be educated on WAGs exposure, thus increasing providers'
knowledge and adherence to WAG exposure reduction practices.
Timely
The educational module development would be completed within a 4-month time frame
and made available to the perioperative providers at a large hospital for three weeks.
Additionally, the full implementation of practice recommendations and the evaluation of
outcomes would be done over 2-months.
SWOT Analysis
To ensure the success of a project and prepare for potential hindrances, it is vital to
perform a SWOT: strengths, weakness, opportunities, and threats analysis. As a result, one can
plan and create potential solutions ahead. As the project aims to increase perioperative providers'
awareness of the effects of WAGs exposure and engagement in practices that decrease exposure
levels, an essential step is the identification of stakeholders. Stakeholders include nurses,
physicians, and healthcare organizations.
Strengths
The educational module's ultimate focus is increasing perioperative awareness of the
occupational dangers inhaled anesthetic agents carry and, as a result, engaging in preventative
practices that decrease the risk of exposure to WAGs. A study by Boiano and Steege showed that
providers lacked precautionary practices to differing degrees.5 Another study by Williams et al.8
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sampled an ISO-Gard mask in the PACU to reduce exposure to WAGs. It concluded that the
mask was effective in reducing the amount of exposure.
Weakness
The assessment of the weaknesses includes issues that can cause a hindrance to the
implementation of the educational module. They can include the organizational culture when it
comes to implementing change.17 Additional factors one has to account for include the leadership
style of the hospital, the degree of cooperation, the dominant characteristics, and the level of
employee involvement in the change process.18 For example, it will be challenging to be a
change agent in an organization that does not promote change and involves its employees in the
change process.
Opportunities
Implementing an educational module for perioperative providers on the risk for exposure
of WAGs in the PACU, thus increasing awareness and precautionary practices, creates an
opportunity to decrease the exposure of WAGs. Hence, the short-term and long-term effects are
decreased as a result. Short-term effects linked to WAG exposure include syncope, headache,
dizziness, and fatigue during working hours, which can pose patient safety concerns, particularly
impaired judgment.13 Long-term effects include immune system alterations, hepatic alterations,
genotoxicity, cancer, and miscarriage.2,4,13
Threats
Potential threats to implementing the project include funding, the turnover rate, the
overwhelming schedule of the stakeholder, or a lack of interest.17 Especially because the
implementation of the project lacks incentives, it is vital that the stakeholders are self-motivated
and interested in mitigating the exposure of WAGs in the PACU.
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DEFINITION OF TERMS
Waste anesthetic gases (WAGs):
Are small amounts of volatile anesthetic gases that leak into the environment.2
Breathing zone:
It is an area encompassing the face of approximately 6 to 9 inches.8
THEORETICAL FRAMEWORK
Vital to implementing the educational module on WAGs exposure is using a middlerange theory to aid in the process. Specifically, Lewin's change theory involves unfreezing,
moving, and refreezing.19 The first step is unfreezing, which entails recognizing that the current
practices are no longer the best way to utilize them. This step also factors in the driving and
restraining forces of change. The next step is moving, which entails implementing a
comprehensive educational program that includes current literature on decreasing WAGs
exposure. Finally, the refreezing stage ensures that implementation stays and becomes the new
status quo.19 To facilitate the final step, once the project is successfully implemented, evaluation
of adherence via surveys will be performed, and yearly retraining will reinforce and ensure
permanent incorporation at the large hospital.
METHODOLOGY OF QUALITY IMPROVEMENT PROJECT
Setting and Participants
Following the Institution Review Board at Florida International University's approval,
this quality improvement project was conducted at a large, private, not-for-profit teaching
hospital in Florida. Surgical procedures such as general surgery, gynecologic, urologic, thoracic,
reconstructive, plastic, orthopedic, neurosurgery, radiation, and diagnostic imaging require
various anesthetic techniques. An estimated 13,000 surgical procedures are performed yearly,
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most performed in an outpatient setting. The quality improvement project participants comprised
only Certified Registered Nurse Anesthetists (CRNAs) with a total of 10.
Protection of Human Subjects
Depending on the Institutional Review Board's grade risk scale on the proposed project,
participants' consent will be obtained via Qualtrics, a HIPAA-compliant software. CRNAs
working at the large hospital were invited to be involved in the project via their work email.
Participation was voluntary, and subjects could withdraw their consent at any time. Potential
benefits to participants include improved knowledge and awareness of WAGs exposure in the
PACU and, as a result, engaging in preventative practices that decrease exposure. Aside from
mild emotional stress or mild physical discomfort from sitting on a chair for an extended period
during the completion of the educational module, participants are not expected to experience any
significant risk, harm, or discomfort during this project. Data on participant knowledge,
perceptions, and practices regarding exposure to waste anesthetic gases were collected
anonymously. Data was password-protected, and only investigators had access to the
information.
Intervention and Data Collection
The project intervention started with the invitation of CRNAs at the large hospital
through Qualtrics via their work email to participate. The education module was limited to 10
minutes to keep the participants' attention. Before providing the educational module, a pre-test
survey via Qualtrics was given to assess the nurse's knowledge of WAG exposure, adverse
effects, and practices that reduce its exposure. After implementing the educational module, a
post-test survey via Qualtrics was given. The educational module contained WAGs exposure,
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occupational risk, adverse effects, and evidence-based practices to decrease exposure.
Demographical data included age, sex, race, and years of practice.
Data Management and Analysis Plan
The data collected were stored electronically, and access was limited to the primary
investigator. Based on the nature of the project, no direct participant identifier was needed,
negating the need to collect any identifiable information. A random identifier number was
assigned to the participants; thus, the data collected was anonymous. Statistical data analysis
compared the survey results before and after implementing the educational module.
TIMELINE
Project Tasks
1. Development of the education module
2. Development of demographic and pre-test survey
3. Choose a HIPPA-compliant software platform to utilize for the project
4. Choose an electronic database to store and compile project data
5. Write up an informed consent
6. Request IRB approval
7. Create and disseminate project invite
8. Administer pre-test survey
9. Implement educational module
10. Administer posttest survey
11. Review and compile participants' progress
12. Analyze project data
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Invite
perioperative
providers to
participate via
work email

Consent of
participants if
needed

Demographic
questionnaire
and Pre-test

Post-test survey

Educational
module
implementation

Analyze project
data

RESULTS
Participant Demographics
After the launch of Qualtrics, 10 participants completed the survey. Female participants
accounted for 60% (n = 6), 30% (n = 3) were males, and 10% (n = 1) preferred not to specify.
The survey participants encompassed individuals from various racial/ethical backgrounds, such
as 40% Hispanics, 30% African Americans, 20% Caucasians, and 10% Asians. All the
participants were CRNAs; however, 60% (n = 6) were Doctoral degree level, and 40% (n = 4)
were master's degree level. The participants had varying levels of experience; 1 to 2 years (n = 1,
10%), 2 to 5 years (n = 3, 30%), 5 to 10 years (n = 2, 20%), and over 10 years (n = 4, 40%). The
participants' demographics are illustrated in Table 1.
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Table 1. Demographics
Demographics
Total Participants

N (%)
10 (100%)

Gender
Male
Female
Prefer not to say

3 (30 %)
6 (60 %)
1 (10 %)

Ethnicity
African American
Caucasian
Hispanic
Asian

3 (30 %)
2 (20 %)
4 (40 %)
1 (10 %)

Medical Profession
Doctorate
Masters

6 (60 %)
4 (40 %)

Experience
1 to 2 years
2 to 5 years
5 to 10 years
Over ten years

1 (10 %)
3 (30 %)
2 (20 %)
4 (40 %)

Pre-Test: Assessment of Baseline Knowledge
The pre-test questions were administered to assess the baseline knowledge of the
participants. The test was administered prior to the implementation of the educational module. In
contrast, the post-test was administered after implementing the educational module. The pre-test
result is shown in Table 2. The pre-and-post-test consisted of identical questions listed below:
1. What organization is responsible for setting exposure limits to waste anesthetic gases?
a. National Institute for Occupational Safety and Health
b. Food and Drug Administration
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c. Occupational Safety and Health Administration
d. Department of Transportation
2. Which providers are NOT at-risk for waste anesthetic gas exposure?
a. OR nurses
b. PACU nurses
c. Nurse anesthetists
d. ICU nurses
e. Surgeons
3. Short-term effects of waste anesthetic gases include?
a. Genotoxicity
b. Cancer
c. Difficulty with judgment
d. Kidney disease
4. Long-term effects of waste anesthetic gases include?
a. Infertility
b. Headache
c. Fatigue
d. Nausea
5. True or False. Chronic exposure to waste anesthetic gases has been linked to short- and
long-term effects?
a. True
b. False
6. True or False. Waste anesthetic gas exposure can be eliminated?
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a.

True

b. False
7. How likely are you to ensure the proper functioning of the scavenging system?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
8. How likely are you to utilize an ISO-Gard mask?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
The results of pre-test questions 7 and 8 are illustrated in Figures 1 and 2. The responses
based on question 7 on the pre-test were as follows, 3 (30%) answered "extremely unlikely," 2
(20%) answered "neither likely nor unlikely," 1 (10%) answered "somewhat likely," and 4 (40%)
answered "extremely likely." While question 8, feedback was as follows, 3 (30%) answered
"extremely unlikely," 3 (30%) answered "somewhat unlikely," 2 (20%) answered "neither likely
nor unlikely," and 1 (10%) answered "somewhat likely," and 1 (10%) answered "extremely
likely."
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Table 2. Pretest Results
Question Number (#)

Number of participants
that answered correctly

Percentage of the correct
answer

#1

2/10

20%

#2

6/10

60%

#3

5/10

50%

#4

6/10

60%

#5

9/10

90%

#6

6/10

60%

Figure 1. Pre-test question 7
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Figure 2. Pre-test question 8

Post-Test: Assessment of Learning
The post-test was administered after the implementation of the educational module. It
was administered to assess knowledge gained after the module's presentation and the probability
of the participants utilizing the suggested practices to reduce WAGs exposure level. Participants
demonstrated improved scores in the post-test survey compared to the pre-test scores. When
asked how likely they are to ensure the proper functioning of the scavenging system in the posttest, 6 (60%) CRNAs responded "extremely likely," and 1 (10%) responded "extremely
unlikely." Furthermore, when asked how likely they are to utilize an ISO-Gard mask, 4 (40%)
CRNAs responded "extremely likely," 3 (30%) CRNAs responded "somewhat likely," and 3
(30%) CRNAs responded "extremely unlikely." Results for post-test questions 1 through 6 are
shown in Table 3, and question 7 through 8 is shown in Figures 3 and 4. While Table 4 illustrates
the improvement in scores after implementing the educational module.
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Figure 3. Post-test Question 7

Figure 4. Post-test Question 8
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Table 3. Post-test Results
Question Number (#)

Number of participants
that answered correctly

Percentage of the correct
answer

#1

8/10

80%

#2

7/10

70%

#3

7/10

70%

#4

9/10

90%

#5

10/10

100%

#6

7/10

70%

Table 4. Pre-test vs. Post-test scores
Question Number (#)

Pre-test score
percentage

Post-test score
percentage

Change

#1

20%

80%

+60%

#2

60%

70%

+ 10%

#3

50%

70%

+20%

#4

60%

90%

+30%

#5

90%

100%

+10%

#6

60%

70%

+10%

DISCUSSION
The virtually administered educational module showed increased knowledge regarding
WAG exposure, its adverse effects, and practices that reduce its exposure when comparing the
pre-test to the post-test survey results. After implementing the module, 80% (n = 8) answered
question 1 correctly, showing a 60% increase in knowledge for the organization responsible for
setting exposure limits to WAGs. Results showed a 20 to 30% increase in the participant's ability
to distinguish between the short- and long-term effects of WAGs exposure. 70% (n = 7) of
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participants identified at-risk providers to WAG exposure as opposed to 60% (n = 6) during the
pre-test survey. 100% (n = 10) of the participants knew that chronic WAGs had been linked to
short- and long-term effects. Additionally, 70% of participants correctly acknowledged that
WAGs exposure could not be eliminated. However, when asked about the likelihood of ensuring
the proper functioning of the scavenging system. 60% (n = 6) of the participants responded that
they were "extremely likely," and 10% (n = 1) responded "extremely unlikely." when it comes to
the utilization of an ISO-Gard mask, 40% (n = 4) responded, "extremely likely," 30% (n = 3)
responded "somewhat likely," and 30% (n = 3) responded "extremely unlikely."
Limitations
The most significant limitation of the quality improvement project was the sample size.
The educational module was disseminated to 34 CRNAs via their work email using Qualtrics; 1
email bounced back and thus could not be delivered. However, after a reminder email was sent
prior to the closure of the Qualtrics link, only 10 CRNAs completed the survey. Another
limitation to consider is the virtual format of the quality improvement project. It creates a unique
type of limitation as supposed to deliver it in person. One must consider the technological
literacy of the invited participants. Additionally, dissemination via email tends to be easily
overlooked, the invitees may need to be more active users of their email accounts, and there is
limited control over ensuring the participants initiate or complete the survey.
IMPLICATIONS OF ADVANCED PRACTICE NURSING
With the first hour being the critical period for a patient during recovery, studies have
shown that levels of WAGs exceeded the NIOSH recommended limit, especially during the first
fifteen minutes to an hour. Perioperative providers in the PACU are at increased risk for
exposure and adverse health effects.8,11,15,16 Most of the literature review analyzed focused on
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mitigating WAG exposure in the OR environment. Hence, implementation of WAGs reduction
practices in the PACU is limited. Implementing the educational module highlighted the need to
increase perioperative provider awareness of WAGs exposure in the PACU. As a result of newly
gained knowledge, participants are willing to engage in evidence-based prevention practices.
With the proper tool and education, perioperative providers ensure their safety while providing
quality care. Further research on WAG exposure and reduction practices in the PACU is still
needed.
CONCLUSION
After implementing the educational module with a total participant of 10, results showed
increased knowledge regarding WAG exposure, its adverse effects, and practices that reduce its
exposure when comparing the pre-test to the post-test survey results. There was a 60% increase
in knowledge for the organization responsible for setting exposure limits to WAGs. Also, a 20%
to 30% increase in the participant's ability to distinguish between the short- and long-term effects
of WAGs exposure. 70% (n = 7) of participants identified at-risk providers to WAG exposure as
opposed to 60% (n = 6) during the pre-test survey. All 10 participants knew that chronic WAGs
had been linked to short- and long-term effects.
Additionally, more than half of the participants knew that WAGs exposure could not be
eliminated. 60% (n = 6) strongly desired to ensure the proper functioning of the scavenging
system. Regarding utilizing an ISO-Gard mask, 40% (n = 4) were extremely likely, and 30% (n =
3) were somewhat likely. Considering the limitations of the project and little research focused on
mitigating WAGs exposure in the PACU, further research is needed.
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Appendix A

CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
"Increasing providers' awareness of waste anesthetic gases exposure in the post-anesthetic care
unit: An educational module"

SUMMARY INFORMATION
Things you should know about this study:









Purpose: Educational module to increase providers' awareness of waste anesthetic gases
exposure in the post-anesthetic care unit
Procedures: If you choose to participate, you will be asked to complete a pre-test, watch
a voice PowerPoint, and then a post-test
Duration: This will take about a total of 20 minutes total.
Risks: The main risk or discomfort from this research is minimal. There will be minimal
risks involved with this project, as expected in any educational intervention, which may
include mild emotional stress or mild physical discomfort from sitting on a chair for an
extended period.
Benefits: The main benefit to you from this research is increasing the participant's
knowledge on the risk for exposure to waste anesthetic gases in the post-anesthetic care
unit and, as a result, engaging in preventative practices that decrease exposure.
Alternatives: There are no known alternatives available other than not participating in
this quality improvement project.
Participation: Taking part in this quality improvement project is voluntary.

Please carefully read the entire document before agreeing to participate.

PURPOSE OF THE PROJECT
You are being asked to be in a quality improvement project. This project aims to increase
providers' knowledge of the potential dangers of waste anesthetic gases exposure in the postanesthetic care unit, along with ways in which perioperative personnel can reduce their
exposure levels.
NUMBER OF PARTICIPANTS
If you decide to participate, you will be 1 of approximately 10 participants.
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DURATION OF THE PROJECT
Your participation will require about 20 minutes of your time.
PROCEDURES
If you agree to be in the project, we will ask you to do the following things:
If you agree to be in the study, we will ask you to do the following things:
1. Complete an online 10-question pre-test survey via Qualtrics, an Online survey product for
which the URL link is provided
2. Review the educational PowerPoint Module lasting 15 minutes via Qualtrics, an Online survey
product for which the URL link is provided.
3. Complete the online 10-question post-test survey via Qualtrics, an Online survey product for
which the URL link is provided.

RISKS AND/OR DISCOMFORTS
The main risk or discomfort from this research is minimal. There will be minimal risks involved
with this project, as expected in any educational intervention, which may include mild emotional
stress or mild physical discomfort from sitting on a chair for an extended period.
BENEFITS
The following benefits may be associated with your participation in this project: An
increased participants' knowledge on the risk for exposure to waste anesthetic gases in the
post-anesthetic care unit, and as a result, engaging in preventative practices that decrease
exposure.
The program's overall objective is to increase the providers' knowledge based on the current
literature.
ALTERNATIVES
There are no known alternatives available to you other than not participating in this project.
However, if you would like to receive the educational material given to the participants in this
project, it will be provided at no cost.
CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent
provided by law. Records will be stored securely, and only the project team will have access to
the records. If in any sort of report we might publish, we will not include any information that
will make it possible to identify you as a participant.
PARTICIPATION: Taking part in this quality improvement project is voluntary.
COMPENSATION & COSTS
There is no cost or payment to you for receiving the health education and/or participating in
this project.
RIGHT TO DECLINE OR WITHDRAW
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Your participation in this project is voluntary. You are free to participate in the project or
withdraw your consent at any time during the project. Your withdrawal or lack of participation
will not affect any benefits to which you are otherwise entitled. The investigator reserves the
right to remove you without your consent when they feel it is in their best interest.
RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
research project, you may contact Blessing Lukoh at 786-314-0383/bluko001@fiu.edu and
Yasmine Campbell at 305-778-0722/ ycampbel@fiu.edu.
IRB CONTACT INFORMATION
If you would like to talk with someone about your rights pertaining to being a subject in this
project or about ethical issues with this project, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.
PARTICIPANT AGREEMENT
I have read the information in this consent form and agree to participate in this study. I have had
a chance to ask any questions I have about this study, and they have been answered for me. I am
providing my informed consent by clicking on the "consent to participate" button below.
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Pretest and Posttest Questionnaire:
Waste Anesthetic Gases in PACU
INTRODUCTION
The primary aim of this QI project is to increase providers awareness of waste anesthetic
gases exposure in the post-anesthetic care unit.
Please answer the question below to the best of your ability. The questions are either in
multiple choice or true/false format and are meant to measure knowledge on waste anesthetic
gases exposure in PACU
PERSONAL INFORMATION
1. Gender: Male

Female

Other________

2. Ages 25 and above: ______
3. Ethnicity: Hispanic Caucasian

African American

Asian

Other_______________
4. Position/Title:

CRNA

Anesthesiologist

5. Level of Education: Bachelors

Masters

Resident
Doctorate

Other ___________

6. How many years have you been a perioperative provider?
Over 10

5-10 years

2-5 years

1-2 years

QUESTIONNAIRE
9. What organization is responsible for setting exposure limit to waste anesthetic
gases:
a. National Institute for Occupational Safety and Health
b. Food and Drug Administration
c. Occupational Safety and Health Administration
d. Department of Transportation
10. Which of the following providers is NOT at-risk for waste anesthetic gases
exposure:
a. OR nurses
b. PACU nurses
c. Nurse anesthetists
d. ICU nurses
e. Surgeons
11. Short-term effects of waste anesthetic gases include:
a. Genotoxicity
b. Cancer
c. Difficulty with judgment
d. Kidney disease
12. Long-term effects of waste anesthetic gases include:
a. Infertility
b. Headache
c. Fatigue
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d. Nausea
13. Chronic exposure to waste anesthetic gases has been linked to short- and long-term
effects?
a. True
b. False
14. Waste anesthetic gases exposure can be totally eliminated?
a. True
b. False
15. How likely are you to ensure the proper functioning of the scavenging system?
a.

Most likely

b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
16. How likely are you to utilize an ISO-Gard mask?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
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Dear Miami Beach Associates Providers,
You are invited to participate in a quality improvement project titled "Increasing providers
awareness of waste anesthetic gases exposure in the post-anesthetic care unit: An educational
module" via the Qualtrics platform. This project is being conducted by Blessing Lukoh, SRNA at
Florida International University (FIU). This study aims to increase the providers' knowledge
based on the current literature, the potential dangers of WAGs exposure, along with ways in
which perioperative personnel can reduce their exposure levels. The results may be reported in
aggregated and presented in advocacy communications, journal articles, poster presentations, and
lectures. This study is a doctoral project.
Participation in this survey is entirely voluntary. You may choose not to participate or to opt or
skip the survey at any time. Regardless of your decision, there will be no effect on your
relationship with the researchers or any other consequences. Best practices will be utilized to
protect the confidentiality of survey data. The survey should take approximately 10-15 minutes
to complete.
The Institutional Review Board has approved this project of FIU. The main risk or discomfort
from this research is minimal. There will be minimal risks involved with this project, as expected
in any educational intervention, which may include mild emotional stress or mild physical
discomfort from sitting on a chair for an extended period. All responses to this survey will
remain anonymous and cannot be linked to the participant. In addition, you may choose to omit
the demographic questions included in the survey if you find them potentially identifiable. No
personal identifying information about you will be collected during the study, and your survey
will be identified only with a random number sampling. Once you submit your completed
survey, there will be no way to withdraw your responses from the study because the survey data
contains no identifying information and will be unable to be traced back to your submission.
While you may not experience any direct benefits from participation, you will be contributing to
a body of knowledge supporting the profession.
If you have any questions about the purpose, procedures, or any other issues relating to this
research project, you may contact Blessing Lukoh at 786-314-0383/bluko001@fiu.edu and
Yasmine Campbell at 305-778-0722/ ycampbel@fiu.edu. If you would like to talk with someone
about your rights to be a subject in this project, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or email at ori@fiu.edu.
Sincerely,
Blessing Lukoh SRNA.
Yasmine Campbell, DNP, CRNA, APRN.
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